These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 22000601)

  • 1. Studying up harm reduction policy: the office as an assemblage.
    Chen JS
    Int J Drug Policy; 2011 Nov; 22(6):471-7. PubMed ID: 22000601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A harm reduction paradox: comparing China's policies on needle and syringe exchange and methadone maintenance.
    Smith K; Bartlett N; Wang N
    Int J Drug Policy; 2012 Jul; 23(4):327-32. PubMed ID: 22377341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. From political controversy to a technical problem? Fifteen years of opioid substitution treatment in Finland.
    Selin J; Hakkarainen P; Partanen A; Tammi T; Tigerstedt C
    Int J Drug Policy; 2013 Nov; 24(6):e66-72. PubMed ID: 24095679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methadone, a contested substance: Danish methadone policy in the 1970s.
    Houborg E
    Int J Drug Policy; 2013 Nov; 24(6):e73-80. PubMed ID: 24120441
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Harm reduction drug policy in Israel: what has been accomplished and what still needs to be done?
    Bonny-Noach H
    Isr J Health Policy Res; 2019 Oct; 8(1):75. PubMed ID: 31619286
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Work and the journey to recovery: exploring the implications of welfare reform for methadone maintenance clients.
    Monaghan M; Wincup E
    Int J Drug Policy; 2013 Nov; 24(6):e81-6. PubMed ID: 24360401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Public health and the Canadian Charter of Rights and Freedoms.
    Paradis G
    Can J Public Health; 2011; 102(6):403. PubMed ID: 22164544
    [No Abstract]   [Full Text] [Related]  

  • 8. Report of Advisory Council on the Misuse of Drugs: AIDS and drug misuse update.
    Raistrick D
    Addiction; 1994 Oct; 89(10):1211-3. PubMed ID: 7804081
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of combination approach on harm reduction programs: the Taiwan experience.
    Lin T; Chen CH; Chou P
    Harm Reduct J; 2016 Jul; 13(1):23. PubMed ID: 27377896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mitigating the risk of HIV infection with opioid substitution treatment.
    Gowing LR; Hickman M; Degenhardt L
    Bull World Health Organ; 2013 Feb; 91(2):148-9. PubMed ID: 23554530
    [No Abstract]   [Full Text] [Related]  

  • 11. The trajectory of methadone maintenance treatment in Nepal.
    Ambekar A; Rao R; Pun A; Kumar S; Kishore K
    Int J Drug Policy; 2013 Nov; 24(6):e57-60. PubMed ID: 23845916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HIV and drugs: a common, common-sense agenda for 2016.
    Buse K; Albers E; Phurailatpam S
    Lancet Glob Health; 2016 May; 4(5):e292-3. PubMed ID: 27080461
    [No Abstract]   [Full Text] [Related]  

  • 13. Malaysia and harm reduction: the challenges and responses.
    Reid G; Kamarulzaman A; Sran SK
    Int J Drug Policy; 2007 Mar; 18(2):136-40. PubMed ID: 17689356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cross-national analysis of the effects of methadone maintenance and needle and syringe program implementation on incidence rates of HIV in Europe from 1995 to 2011.
    Marotta PL; McCullagh CA
    Int J Drug Policy; 2016 Jun; 32():3-10. PubMed ID: 27212656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Zoned Out: "NIMBYism", addiction services and municipal governance in British Columbia.
    Bernstein SE; Bennett D
    Int J Drug Policy; 2013 Nov; 24(6):e61-5. PubMed ID: 23680227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The evidence does not speak for itself: The role of research evidence in shaping policy change for the implementation of publicly funded syringe exchange programs in three US cities.
    Allen ST; Ruiz MS; O'Rourke A
    Int J Drug Policy; 2015 Jul; 26(7):688-95. PubMed ID: 25979789
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Buprenorphine/naloxone and methadone maintenance treatment outcomes for opioid analgesic, heroin, and combined users: findings from starting treatment with agonist replacement therapies (START).
    Potter JS; Marino EN; Hillhouse MP; Nielsen S; Wiest K; Canamar CP; Martin JA; Ang A; Baker R; Saxon AJ; Ling W
    J Stud Alcohol Drugs; 2013 Jul; 74(4):605-13. PubMed ID: 23739025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Assessing perceptions about medications for opioid use disorder and Naloxone on Twitter.
    Tofighi B; El Shahawy O; Segoshi A; Moreno KP; Badiei B; Sarker A; Krawczyk N
    J Addict Dis; 2021; 39(1):37-45. PubMed ID: 32835641
    [No Abstract]   [Full Text] [Related]  

  • 19. Examining structural violence in opioid pharmacotherapy treatment in Australia: sweating the "small stuff" in a liberal paradise.
    Treloar C; Valentine K
    Int J Drug Policy; 2013 Nov; 24(6):e11-3. PubMed ID: 23711673
    [No Abstract]   [Full Text] [Related]  

  • 20. Heroin-assisted treatment in Switzerland: a case study in policy change.
    Uchtenhagen A
    Addiction; 2010 Jan; 105(1):29-37. PubMed ID: 19922519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.